Market analysts predict the global bioactive fillings market will experience a 9.2 percent compound annual growth rate between 2017 and 2023.
Here are six takeaways:
1. The greater emphasis on restorative procedures, rising safety and success of bioactive fillings treatment and technological advancements are the major market drivers through the forecast period.
2. During the forecast period, the market will have to overcome mechanical weaknesses, high costs, frequent rejections and poor load-bearing capacity.
3. Key market competitors include Septodont, DePuy Synthes, Medtronic, Stryker, Zimmer Biomet, Arthrex and Baxter.
4. The number of restorative procedures in the U.S. and Canada as well as the high expenditures on healthcare gives the Americas the largest market share.
5. Europe holds the second largest market share due to its growing medical device industry and healthcare penetration.
6. The Asia Pacific region is predicted to see the greatest market growth during the forecast period due to its growing healthcare sector.
More articles on devices and implants:
Interventional spine devices market to experience 10.5% CAGR through 2021: 4 highlights
J&J reports declining spine sales in Q3 – what to expect in Q4
Highmark 1st private payer with exclusive coverage for Paradigm's coflex: 5 highlights